Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jullian

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Developments in Biological Standardization|January 1, 1992
C-fos and c-myc modulation, mitogenic effect and Ia expression in the P388D1 murine macrophage line treated by immunomodifiersM M Teyssier, Y C Le Garrec, E H Jullian, et al.
Immunopharmacology and Immunotoxicology|January 1, 1992
Expression of c-fos and c-myc oncogenes in the P388D1 murine macrophage line treated by immunomodulators: absence of direct correlation with DNA synthesisM M Teyssier, Y C Le Garrec, E H Jullian, et al.
European Journal of Biochemistry|June 15, 1995
Characterization of a human perinatal myosin heavy-chain transcriptE H Jullian, A M Kelly, A J Pompidou, et al.
Critical Reviews in Oncology/Hematology|August 3, 2007
An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a studyH LeCaer, P Fournel, H Jullian, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2012
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)H LeCaer, L Greillier, R Corre, et al.
British Journal of Cancer|September 22, 2011
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)H LeCaer, F Barlesi, R Corre, et al.
The Journal of Biological Chemistry|February 25, 1990
The human embryonic myosin heavy chain. Complete primary structure reveals evolutionary relationships with other developmental isoformsH H Stedman, M Eller, E H Jullian, et al.
Respiration; International Review of Thoracic Diseases|March 20, 2004
Visits to the emergency room for asthma attacks and short-term variations in air pollution. A case-crossover studyS Boutin-Forzano, N Adel, L Gratecos, et al.
Journal of Muscle Research and Cell Motility|October 14, 2000
Human skeletal myosin heavy chain genes are tightly linked in the order embryonic-IIa-IId/x-ILb-perinatal-extraocularJ B Shrager, P R Desjardins, J M Burkman, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Developments in Biological Standardization|January 1, 1992
C-fos and c-myc modulation, mitogenic effect and Ia expression in the P388D1 murine macrophage line treated by immunomodifiersM M Teyssier, Y C Le Garrec, E H Jullian, et al.
Immunopharmacology and Immunotoxicology|January 1, 1992
Expression of c-fos and c-myc oncogenes in the P388D1 murine macrophage line treated by immunomodulators: absence of direct correlation with DNA synthesisM M Teyssier, Y C Le Garrec, E H Jullian, et al.
European Journal of Biochemistry|June 15, 1995
Characterization of a human perinatal myosin heavy-chain transcriptE H Jullian, A M Kelly, A J Pompidou, et al.
Critical Reviews in Oncology/Hematology|August 3, 2007
An open multicenter phase II trial of docetaxel-gemcitabine in Charlson score and performance status (PS) selected elderly patients with stage IIIB pleura/IV non-small-cell lung cancer (NSCLC): the GFPC 02-02a studyH LeCaer, P Fournel, H Jullian, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2012
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study)H LeCaer, L Greillier, R Corre, et al.
British Journal of Cancer|September 22, 2011
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study)H LeCaer, F Barlesi, R Corre, et al.
The Journal of Biological Chemistry|February 25, 1990
The human embryonic myosin heavy chain. Complete primary structure reveals evolutionary relationships with other developmental isoformsH H Stedman, M Eller, E H Jullian, et al.
Respiration; International Review of Thoracic Diseases|March 20, 2004
Visits to the emergency room for asthma attacks and short-term variations in air pollution. A case-crossover studyS Boutin-Forzano, N Adel, L Gratecos, et al.
Journal of Muscle Research and Cell Motility|October 14, 2000
Human skeletal myosin heavy chain genes are tightly linked in the order embryonic-IIa-IId/x-ILb-perinatal-extraocularJ B Shrager, P R Desjardins, J M Burkman, et al.
Pageof 2